ekohealth.comHealthcare / Medical DevicesFounded: 2013Funding to Date: $164.33MM
Eko Health is a digital medical device company. Using its AI detection platform, SENSORA, the company has a mission of helping healthcare professionals detect and monitor heart and lung disease with its portfolio of digital stethoscopes. Tools featured in the company include digital stethoscopes, ECG + stethoscopes, Eko mobile application, and the SENSORA platform. Eko Health was founded by Connor Landgraf, Jason Bellet, and Tyler Crouch in 2013 and is headquartered in San Francisco, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/05/2024 | Series D | $41MM | $xx.xx | $271.32MM | ARTIS Ventures, Highland Capital Partners, NTTVC, Questa Capital | |
Price per Share
$xx.xx
Shares Outstanding
23,889,987
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
ARTIS Ventures, Highland Capital Partners, NTTVC, Questa Capital
|
||||||
03/22/2022 | Series C-1 | $30MM | $xx.xx | $395.32MM | Morningside Technology Ventures, PROOF | |
Price per Share
$xx.xx
Shares Outstanding
9,779,631
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Morningside Technology Ventures, PROOF
|
||||||
11/09/2020 | Series C | $65MM | $xx.xx | $207.1MM | Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, 3M Ventures | |
Price per Share
$xx.xx
Shares Outstanding
38,701,985
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, 3M Ventures
|
||||||
09/25/2019 | Series B | $20MM | $xx.xx | $58.81MM | Artis Ventures, DigiTx Partners, NTTVC, 3M Ventures, Mayo Clinic, Seraph Group, XTX Ventures | |
Price per Share
$xx.xx
Shares Outstanding
21,815,002
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Artis Ventures, DigiTx Partners, NTTVC, 3M Ventures, Mayo Clinic, Seraph Group, XTX Ventures
|
||||||
03/01/2018 | Series A | $5MM | $xx.xx | $15.98MM | Artis Ventures, Strategic Partners, Dreamlt Ventures, 1812 Ventures, Founder.org | |
Price per Share
$xx.xx
Shares Outstanding
8,430,282
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Artis Ventures, Strategic Partners, Dreamlt Ventures, 1812 Ventures, Founder.org
|
||||||
03/12/2015 | Series Seed | $3.33MM | $xx.xx | $9.52MM | John Noonan | |
Price per Share
$xx.xx
Shares Outstanding
5,037,503
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
John Noonan
|